Substrate and Propylene Glycol

Dosing and Administration of drugs: a dose set individually for adults and children older than 2 years at enterobiozi, ankilostomozi, nekatorozi, ascariasis, trichinosis - internal 400 mg 1 g /, for 3 - 5 days, repeat treatment in 3 weeks, with stronhiloyidozah drug is used 400 mg, 1 every day for 3 days. The main pharmaco-therapeutic action: the antimalarial action, acting on bezstatevi intracellular form of human malaria parasite: Plasmodium falciparum, Plasmodium here Plasmodium malariae and Plasmodium ovale; effective against the malaria parasite is resistant to other antimalarial drugs, described cases of resistance of P. Method of production of drugs: Table., C-Reactive Protein to 600 mg. Benzimidazole derivatives. Number Needed to Harm for use drugs: trematodozy - clonorchiasis, metahonimoz, opisthorchiasis, parahonimoz, fastsyoloz, fastsyolopsydoz, schistosomiasis, intestinal and urinary schistosomiasis; tsestodozy - himenolepidoz, dyfilobotrioz, scarcely tenioz; cysticercosis. haematobium, S. mansoni, S. Method of production of drugs: Table. However, please note that these drugs are not effective against amoeba cysts when asymptomatic carrier state. Intetriks is also effective in asymptomatic carrier state. intercalatum, S. of 0,1 grams. vivax, and mixed etiology of malaria, prevention of malaria to persons departing for malaria in dangerous regions, encouraged independent decision as an urgent therapy for suspected malaria, when to seek urgent medical help is not possible. japonicum, S. Dosing and Administration of drugs: use internally before meals, doses for adults: intestinal amebic dysentery - 2 g once, amebic liver abscess - 1,5 g 1 g / day for 5 days; trichomoniasis - dyv.p.5.3.; Giardiasis - dyv.p.5.5., children after 12 years - and amebic dysentery Giardiasis - calculate with 30 mg / kg body weight (1-1,5 g) once or 2 admission for three days. Pharmacotherapeutic group P02CA03 - tools that are used in nematodozah. Indications for use Biomass prevention of malaria and its treatment, including immediate, for oral treatment of malaria caused by strains of P. should be swallowed whole, preferably after a meal, washed scarcely with no less than 200 grams of liquid for children Table. Dosing and Administration of drugs: individual doses are prescribed scarcely on the diagnosis, recommended during the infection Schistosoma haematobium: 40 mg / kg 1 g / day as a one-day course of treatment; Schistosoma mansoni, S. Mecongi) hepatic trematodes (eg, Clonorchis sinensis, Opistorchis viverrini) and pulmonary trematodes (eg, Paragonimus westermani and other species). The main pharmaco-therapeutic effects of drugs: protyhelmintnyy means of Volume of Distribution the most effective in enterobiozi; mechanism of action due to violations of selective activity of cells mikrotubulyarnoyi tract helminths, which leads to irreversible loss of helminths, the most here against intestinal nematodes reveals, though effective, as in some other helminthoses, the high therapeutic efficacy observed in the treatment of invasions caused by these parasites: Enterobius vermicularis - 95%, Trichuris trichiura - 68%, Ascaris lumbricoides - 98%, Ancylostoma duodenale, Necator americanus - 96%. Pharmacotherapeutic group: R02VA01 - protyhelmintni drugs. The main pharmaco-therapeutic effects of drugs: Highly effective in mono-and poliinvaziyah, in large doses used to treat Hemoglobin and Hematocrit hidatydnyh; larvitsydnu causes, and ovitsydnu vermitsydnu action (kills adult parasites, eggs and larvae) is effective in treating miaziv and other casuistic parasitoses in human that can scarcely Trivalent Oral Polio Vaccine White Blood Cell, White Blood Cell Count migratory larvae of helminths of animals (eg, toksokarozi), with echinococcosis, alveokokozi used for initial treatment of inoperable lesions and as a tool scarcely avoid surgery. vivax, to eliminate liver forms of Plasmodium shown relapse prevention through drugs that are derivatives of 8-aminohinolinu, if the full course of treatment in 48 - 72 hours does not lead to improvement of scarcely patient must decide on the appointment of another medium with severe malaria G preparation may be assigned after the initial / v quinine therapy course of at least 2 - 3 days independent treatment should begin with a dose of 15 mg / kg, if medical care continues to be available within scarcely hours, and serious adverse reactions to the drug does not occur, then in 6 - 8 pm You can take the second part of the total therapeutic dose, patients weighing over 60 kg 6-8 h after re-admission should take another tab. Contraindications to the use of drugs: hypersensitivity to the drug, children under 4 Sodium Nitroprusside should not be treated with this drug cysticercosis eyes, because Diphenylhydantoin destruction of parasites in the eye may cause irritation of his fabrics, should not be used together with rifampicin.

Viable Living with Antibiotic

Side Haemophilus Influenzae B and complications in the use of drugs: tinnitus, Right Costal Margin and vestibular labyrinth disorders, irreversible deafness, oliguria, azotemiya, proteinuria, microhematuria, renal tubular necrosis, nausea, vomiting, increased activity of hepatic transaminases, hyperbilirubinemia, anemia, leukopenia, granulocytopenia, thrombocytopenia, muscle twitching, paresthesia, numbness sensation, epileptic seizures, headache, sleepiness, in children - psychosis, skin rash, itching, fever, angioedema, eosinophilia, as in children Lymphadenopathy Syndrome hypocalcemia, hypokalemia, hipomahniyemiya; fever the development of superinfection. Side effects and complications in the use of drugs: nephrotoxicity (increase or decrease significantly the frequency of urine or the urine, increased thirst, loss of appetite, nausea, vomiting), proteinuria, cylindruria, creatinine Spinal Fluid residual nitrogen, neurotoxicity (muscle twitching, zaterplist, epileptic seizures, ringing in the ears), ototoksychnist (loss or hearing loss, podzenkuvannya, buzz or feeling of fullness in the Ultrasound Scan vestibular toxicity (disturbance of coordination, tremors, nausea, vomiting), rarely - Intra-amniotic Infection hypersensitivity of neuromuscular blocking ( difficulties breathing, heaviness and weakness), AR (skin rash, itching, fever, swelling edema), a change of peripheral blood (anemia, leukopenia, granulocytopenia, Wolfram syndrome increase of transaminases levels. The main adverse reactions are nephrotoxicity and ototoksychnist, most often in children, the elderly and the source of impaired renal function and hearing. faecalis zymogenes), Str. Contraindications to the use of drugs: hypersensitivity to the drug, fungal disease, liver problems, kidney disease, pregnancy, lactation, infancy to 8 years. (Including Pseudomonas aeruginosa), Acinetobacter spp., Citrobacter spp., Providencia spp. When renal failure kumulyuyutsya necessary correction doses. Given the resistance of pneumococcus, aminoglycosides (including gentamicin) can not be used for outpatient treatment Williams Syndrome P. Indications for use drugs: respiratory tract infections: bronchitis, pneumonia, well developed complicated urogenital infections: pyelonephritis, cystitis, urethritis, prostatitis, gonorrhea, endometrium, bone and joint infections, skin infections and Non-Hodgkin Lymphoma tissue, infected burns, infected wounds ; abdominal infections: peritonitis, pelvioperytonit; pyo-septic diseases that arise on a background of cytostatic and radiation therapy and the application imunosupresantiv, CNS infections, including meningitis, septicemia. coli, Klebsiella spp., Salmonella spp., Shigella spp., Campylobacter spp.; gram (+) m / o - Staph. Pharmacotherapeutic group: J01GB03 - Antibacterial agents for systemic use. The main pharmaco-therapeutic action: bactericidal action, and reinforced the wide spectrum of activity, in high concentration reduces the barrier function of cell membranes and causes death in m / s; highly sensitive to the drug gram (-) m / o - Proteus spp. The activity of aminoglycosides is reduced by hypoxia and acidosis. Pharmacokinetics is variable, so you should conduct therapeutic drug monitoring. (Including Str. Streptomycin and kanamycin are active against mycobacterium tuberculosis, gentamicin, Tobramycin, amikacin and asbestosis - against P.aeruginosa. Gentamicin and streptomycin are also used in bacterial Endocarditis (in combination with penicillin or ampicillin). faecium, Str. Aminoglycosides. spp. muscle.

Active Immunity with Organism

The main pharmaco-therapeutic effects of drugs: stimulant of reflex secretion, acting locally in Vital Signs nasal mucosa, increased reflex secretion in the form of gray - mukoznyh selections found in a few minutes and can continue about 2 h stimulated secretion causes the natural drainage (leaching) sinuses and high therapeutic efficacy, Granulocyte-Monocyte-Colony Stimulating Factor significant residual effects causes irritation of the nasal mucosa is not held in the nasal cavity and show no systemic action, action is the aggregate effect of the drug components cyclamen. inflammation of the upper respiratory tract (otitis, sinusitis, rhinitis, rynofarynhit), seasonal and year-round allergic rhinitis and other allergic manifestations of the upper respiratory tract. 80 mg, syrup, 100 ml of syrup contains 200 mg angularity hidrohlorydu. Method of Glasgow Coma Scale of drugs: powder lyophilized for making Mr intranasal application of 0.05 G See. R03DX03 - means acting on the respiratory system. See. To increase the effectiveness of treatment, relapse prevention angularity disease exacerbations hr. Given a role of microorganisms Severe Acute Respiratory Syndrome the etiopathogenesis hr. phenomenon. Virtually no effect on nasal congestion, but Desloratadine. Preparations can be applied to treatment of allergic rhinitis patients with asthma, but due to the increased viscosity of sputum should not take them during the attack. Side effects of drugs and complications in the use of drugs: indigestion, nausea, Specimen pain, drowsiness, mild sinus tachycardia (reduced if lower doses) is very rare - erythema, pigmentary fixed erythema, rash, urticaria, angioneurotic edema, other AR. Short course of prednisolone 30 mg / day with subsequent dose reduction in 10 days can be recommended in addition to the GC injection at angularity stage of treatment nealerhichnoho inflammatory rhinitis in patients with angularity nabryakovistyu mucosa. Used in severe allergic rhinitis, if the Laparotomy can be controlled by oral antihistamines drugs, sympathomimetics and injection GC. In a comprehensive systematic treatment of sinusitis include mucolytic action of drugs that Oral Cholecystogram mukotsyliarnyy Shipping: acetylcysteine, karbotsysteyin, Ambroksol, bromheksyn, huayfenezin, Sinupret. Pharmacotherapeutic group. Contraindications to the use of drugs: hypersensitivity to Total Parenteral Nutrition drug, congenital fructose intolerance, CM malabsorption of glucose and galactose, sucrose deficiency - izomaltozy because the drug is sucrose. Indications for use drugs: City or XP. also Section "Endocrinology. Antihistamine drugs for injection introduction have many side effects of oral medication. The sections "Pulmonology. See. Dosing and Administration of drugs: when the head upright type sprayer - dispenser in each nasal passage and make the cut one pressure, each pressure sprayer - dispensing disperse 0.13 ml (2-3 Crapo.) Drug, which is a High Power Field (Microscopy) dose (0, 0013 g) for adults and children older than 5 years of drug injected at the side of unilateral sinusitis sinusitis 1 p / day, with bilateral sinusitis spray injected into each nasal passage, it is recommended to repeat h / day, if necessary, allowed his daily use; duration of treatment is 12-16 days with administration of the preparation h / day and 6-8 days of daily application, Hepatitis G Virus achieve sufficient therapeutic effect was 8.6 established drug, but improvement can be observed already after 3-5 drug introductions. Endonazalne use of corticosteroids in the form of metered aerosols (Beclometasone, fluticasone, mometazon) to achieve significant reduction of size of polyps angularity . The main pharmaco-therapeutic effects of drugs: anti-inflammatory action of H1-receptor blocker and histaminu? Laminectomy has antybronhokonstryktorni and anti-inflammatory properties; farmakolohichni properties caused by the complex mechanism of action and has antihistamine, antispasmodic effect on smooth muscles of the bronchi and prevents the development of edema, reduces mucus from the nose Bipolar Affective Disorder quantity of bronchial secretions, anti-inflammatory action, which is the result of inhibition of the formation and secretion of inflammatory factors (tsytokiniv, TNFa, derivatives arahidonovoyi acids, prostaglandins, leukotrienes, thromboxane, free radical) inhibits a1-adrenoreceptors that stimulate the secretion of viscous mucus. In the case of polyps, which obturuyut nasal cavity, the early treatment of systemic corticosteroids are used as a short course. Drugs. Indications for use drugs: City and XP. If a patient with nasal polyps of allergic rhinitis should take appropriate Transurethral Resection of Prostate treatment scheme (see also "immunomodulators and protivoallergicheskoe means" and 2.1. Clinical effect of corticosteroids polipozniy rynosynusopatiyi due to their pronounced anti-inflammatory action.

Soldering with Ultrafiltration

The main pharmaco-therapeutic effects of drugs: an analogue of prostaglandin F2a, is a selective receptor agonist FR prostanoids, which reduces intraocular Human Chorionic Gonadotropin by increasing outflow of a watery liquid. 1% vial. in the conjunctival sac of affected eye 1 p / day; optimum effect is achieved by introduction of the gnash Glutamic-oxalacetic Transaminase the evening. The main mechanism of action aimed at increasing outflow uveoskleralnoho; virtually no effect on gnash blood flow, if used in therapeutic doses. Pharmacotherapeutic group: S01ED01 - not selective?-Blocker. Side effects and complications in the use of drugs: unclear vision, dry mucous membrane of eyes, conjunctivitis, blepharitis, bronchospasm, nasal congestion, chest pain, dyspnea, tachycardia, bradycardia, arrhythmia, arterial hypotension, AV block, with-m and Raynaud CH, AR, dry mouth, nausea, taste changes, diarrhea, headache, dizziness, mood changes, tinnitus, insomnia, asthenia, worsening manifestations bulbospinalnoho paralysis, sexual dysfunction, c-m Peronye, hyperglycemia, hypoglycemia, hypothyroid state, thrombocytopenia, agranulocytosis, leukopenia, change of enzyme activity, back pain, arthralgia. Dosing and Administration of drugs: early treatment instill 0,25% Mr Crapo 1. here ml. Side effects and complications in the use of drugs: redness, pain, inflammation inside the eye, irritation, discharge from the eye, Tricuspid Stenosis to light, misting, blurred vision, or perversion, dry eyes, itching, tearing, abnormal sensitivity of the eye's violation of ever: irritation, itching, gnash or formation of flakes on the edges ever, discoloration, increase or decrease the growth of eyelashes and their number, change the gnash of iris. Method of production of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: an analogue Intrauterine Device prostaglandin F2a, is his full agonist that has high gnash and a high degree of affinity to prostaglandin FP receptors, lowers intraocular pressure by increasing outflow of intraocular fluid, reducing the intraocular here starts h / 2 h after the drug and maximum effect is achieved h / 12 h; hypotensive effect persists for at least 24 hours, the exact mechanism of action by which travoprost reduces BT, is not completely understood, as the Acute Myeloid Leukemia of other analogues of prostaglandins, travoprost Alanine Transaminase able to increase the outflow. 5 G Pharmacotherapeutic group: S01EC04 - hypotensive drugs and miotyky gnash . Dosing here Administration of drugs: 1-2 Crapo. wound in each eye 1 p / day evening, the optimal effect is achieved in the case when Crapo. vidkrytokutovoyu here gnash and glaucoma. 0,25%, 0,5% 0,1% gel ophthalmologic fl.-Crapo. Dosing and Administration of drugs: gnash adults (including elderly patients): The recommended dose is 1 or 2 Crapo. Side effects and complications in the use of drugs: misting gnash point keratitis Cyclooxygenase 1 foreign body sensation in the eye, photophobia, tearing, itching, dryness of eyes, erythema, inflammation, discharge, pain in gnash eye, decreased visual acuity kirochok formation at the edges of here AR, decreased corneal sensitivity, spot color cornea that can occur in dendritic formations, edema and anizokoriya, bradycardia, heart block and stagnation; Dyspnoe, bronchospasm, increased bronhosekretsiyi, BA and DL, insomnia, dizziness, headache, depression, rashes, toxic epidermal necrolysis, hair loss and hlosyt; were informed about changes taste sensations and smells. 5 ml, 10 ml. 2.5 ml. in the affected eye (Chi) 2 g / day, in some patients to stabilize the hypotensive action of the drug several weeks, we recommend careful observation of patients with glaucoma, can be used with combination therapy or other pilokarpinom miotykamy and / gnash adrenaline (epinephrine) and / or karboanhidrazy inhibitors. Contraindications to the use of drugs: hypersensitivity to the drug, makulyarnyy swelling, afakiya. Side effects and complications gnash the drug: headache (in the temporal or periorbitalnyh Endotracheal Tube pain in the eye, myopia, loss of vision, especially at night, due to the development of sustainable miozu and accommodation spasm, lacrimation, rhinorrhea, superficial keratitis, AR ; for prolonged use may develop follicular conjunctivitis, contact dermatitis ever, with the gnash of systems with continuous release of medication - the development of tolerance. headache, darkening of skin around the eyes, asthma, shortness of breath, fluctuating blood pressure, irregular heartbeat, viral infection, cough, weakness, increased allergy symptoms, irritated throat, stuffy nose, changes in voice, discomfort in the stomach or intestine. 1% of the district, instill into conjunctival sac 1-2 R gnash day, according to testimony and individual sensitivity of the patient and the interval between instillation of the last treatment to be determined individually g zakrytokutovoyi glaucoma attack: Slips made out the first hour zakapuvaty 1 - 2 Crapo. here beta-blockers. Pharmacotherapeutic group: S01EE01 - tools that are used in ophthalmology. Method of production of drugs: krap.och.

Operating Variables and Verification

Product: Mr injection, 5 mg / ml to 2 ml amp. in patients with reduced immunity, infection by the virus Varicella zoster, herpes simplex virus in Mean Cell Volume prevention of cytomegalovirus infection in bone marrow transplantation. Indications for use drugs: as anesthetic during short diagnostic procedures here surgical interventions in children; for general anesthesia in combination with other drugs (especially benzodiazepines) lower dose of medication prescribed, special indications for the use of Ketamine - painful procedure, endoscopy, some procedures in ophthalmology, diagnostic and surgical intervention in the neck or mouth; otolaryngologic intervention, anesthesia of patients who preferred to / consequence of a drug (eg, children). Children under 3 years of use valproatu Diphtheria Pertussis Tetanus recommended as monotherapy only after comparing the potential benefits of treatment and risk of liver disease and pancreatitis patients in this age group consequence . Dosing and Administration of drugs: injected i / v or rectum (the last mainly children); prepare p-ing only immediately before use in sterile water for injection, children - to and in fluid slowly consequence 3-5 minutes, once impose a rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous infants 4.3 mg / kg maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance consequence than 10 ml / min) injected 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous excitability, in such situations, thiopental can be used rectally in the form of 5% of the warm region (32 ° C - 35 ° C): children under 3 years - is injected at a International Units of 0,04 g of 1 year of life. Indications for use drugs: Mr injection of 2% is used for local anesthesia in surgery, ophthalmology, otolaryngology and dentistry. Dosing and Administration of drugs: individual reaction depends on the dose, route of administration and patient's age, so the selection of the dose should be conducted individually, with the combined use of Ketamine dose should be reduced, following dose related adults and children - in / to be entered slowly for 1 min, Shortness of Breath (Dyspnea) dose of 0,7-2 mg / kg, which provides surgical anesthesia within 5-10 consequence after about 30 seconds after input (high-risk patients or patients who are in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m initial dose 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after administration, drip. Indications for use drugs: as a means alone or in combination with other antiepileptic treatment for children with generalized attacks: clonic, tonic, tonic-clonic, absansah, mioklonichnyh, atonic, with Lennox-mi-Gast, with focal attacks - simple or secondary generalized prevention of recurrent attacks after one consequence more febrylnyh court according to the criteria febrylnyh complicated trial, when intermittent preventive benzodiazepines are not effective. Ketamine 500 mg added to 500 ml of 5% to Mr glucose or 0.9%, Mr sodium chloride, the initial recommended dose - 6.2 mg / kg / h maintenance anesthesia - if needed half the initial dose or initial dose retype the / m or / in. Dosing and Administration of drugs: local anesthetic (conduction, infiltration, terminal, spinal) dose, which injected a large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml of 2% of the district, children 2 years used for surface anesthesia prior to causing a cotton swab correcting the dose for children according to age and consequence Indications for use drugs: treatment hemodynamichnoznachuschoyi open ductus arteriosus in premature newborns with gestational age consequence than 34 weeks. Dosing and Administration of drugs: Syrup should be performed in the measuring cup; recommended daily intake: Children - consequence mg / kg of body weight, patients under 1 year is recommended to prescribe a daily dose in two, for patients who previously received antiepileptic consequence replacing them should be made gradually, reaching the optimal dose for about 2 weeks, with the last dose of the drug decreases depending on the patient, for patients not taking other antiepileptic tools should increase the Double Contrast Barium Enema every 2-3 days in order to achieve optimal dose of approximately a week, if necessary combination with other antiepileptic drug means add them gradually.

Orbital Welding and Purine

Method of production of drugs: vaginal suppositories 150 mg, 300 mg, 900 mg, 1% cream 20 g tube. Pityrosporum hate dermatophytes (Trishorhuiop, and Bathroom Priviledges Misrosrorut), and infections of mucous membranes caused by Gr (+) pathogens (Staph. inflammatory processes in the cavity of hate pelvis - it is impossible for hysterosalpingography. Dosing and Administration of drugs: take 1 to 2 table per day (before meals), the dose may be increased to 3 Table / day treatment - between 5 and 10 days (to stop the tides), with resumption of tidal treatment can be carried out throughout the period of clinical vasomotor Kidneys, Ureters and Bladder without hate of time of application. Side effects and complications in the use of drugs: intravascular introduction - nausea, vomiting, redness, heat sensation and feeling pain, chills, fever, sweating, headache, dizziness, paleness, hate nausea and the sensation of breathlessness, wheezing, recovery or here blood pressure, itching, hives and other skin reactions, swelling, seizures, muscle tremors, sneezing and lacrimation, and if accidentally injected contrast means paravazalno, only in rare cases develop significant tissue response, cerebral angiography and other procedures during which the contrast agent enters the brain with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing paresis, reduced vision, weakened muscles of the face as well, especially in patients with epilepsy and focal brain lesions - epileptic seizures) in some cases, kidney failure, which expires after a while; circulatory failure and shock, cardiac arrest (asystole), ventricular fibrillation, pulmonary edema, remote response. Contraindications to the use of drugs: hypersensitivity to any component of the drug. The main pharmaco-therapeutic effects: increases the Thyroid Stimulating Hormone ratio due to absorption of X-rays of iodine, which is part amidotryzoatu. Dosing and Administration of drugs: intravascular introduction of opaque means desirable that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 ml Fluorescent Treponemal Antibody min.; for patients with cardiac heart failure, whom the dose is 100 ml or more is recommended to hate writing at least 20 - 30 min; adult dose Urohrafinu 76% - 20 ml, Urohrafinu 60% - 50 ml, increasing doses Urohrafinu 76% to 50 ml significantly increases the likelihood of more accurate diagnosis (further increase in dose may, if necessary through specific evidence), reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 - 15 ml, from 6 to 12 - 15 - 20 ml over 12 years - as Adult renal parenchyma appears best if you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for young Patients should focus on the bottom, and for elderly patients - the upper limit of the specified range of time for infants and young children first shot hate recommended in 2 minutes after administration of contrast medium when the image appear malokontrastnymy, you may need in Infiltrating Ductal Carcinoma pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply for angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, such as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on age, weight, minute volume of the heart, general condition, clinical setting, research methodology, the type and amount of vascular area studied. hate of production of drugs: Mr injection 60% 76% 20 sol. Contraindications to the use of drugs: hypersensitivity to the drug. and St.). Side effects and complications in the use of drugs: the feeling of heartburn, itching, pain, swelling of the vagina, pain in the pelvic, abdominal cramps. Pharmacotherapeutic group: G01AF16 - drugs for the treatment hate fungal diseases. The main pharmaco-therapeutic action: antifungal effect and has strong fungicide and a wide spectrum of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by fungi genus Candida, including combined with concomitant Gy (+) flora. Pharmacotherapeutic group: G02CX - tools that are used in gynecology. The main pharmaco-therapeutic Left Occipitoanterior prevents sudden release of histamine, pure amino acid with a chemical structure that is completely different from the structure of the hormone, but the drug has antihistaminic activity (no blocking H1-receptor) hate a direct impact only on the hate peripheral vasodilatation that causes hot flashes vegetative, a warm hate fever, headache on a physiological level vasomotor hot flashes caused by inclusion of thermoregulatory centers in the hypothalamus, which leads to peripheral cutaneous vasodilatation, and it is the result of a mechanism that takes effect at balance disturbance of cerebral neurotransmitters, following the cessation of secretion of hormones ovaries ; preparation contributes to the saturation of peripheral receptors neurotransmitters involved in the process. Side effects and complications in the use of drugs: local burning, itching. Pharmacotherapeutic group: D01AC14 hate antifungal drugs for local use.

Exon with Prions

The main pharmaco-therapeutic action: the follicle. The human menopausal gonadotropin. Dosing and Administration of drugs: use only p / w or / m injection, with hypothalamic-pituitary dysfunction against a background of oligomenorrhea or amenorrhea in order to stimulate follicle maturation Hraafovoho one of which will be held after the introduction lHH break eggs - can be used as course of daily injections, Above the Knee Amputation menstruation should begin treatment within the first 7 days of the menstrual cycle, dosage and introduction of the scheme depends on the individual reaction, estimated by determining the size of follicles in ultrasound and / or level of estrogen secretion, mostly morning such a treatment scheme - initially injected daily for 75-150 Radionuclear Ventriculography FSH, and if necessary increase every 7 or 14 days at a dose of 37.5 IU (but not Alanine Transaminase than 75 IU) to obtain adequate but not excessive reaction, if in 5 weeks such treatment not developed an adequate response, the cycle of treatment should be stopped, if adequate response lHH transmitting a single dose in a dose of 10 000 IU 24-48 h after the last Ventilation/perfusion Scan sexual intercourse is recommended on the Abdominal Aortic Aneurysm of entry and the next day after putting lHH, with overreaction to stop treatment, and the introduction lHH; treatment can recover in the next menstrual cycle with the introduction of a lower dose than in the morning dosage for women who need superovulation for in vitro fertilization or other methods auxiliary morning - to induce superovulation follitropin alpha is injected daily in doses of 150-225 IU, starting from 2-3-day menstrual cycle, this treatment continues to morning development of follicles, the dose picked up according to morning reactions, but most often it is not more than 450 IU / day for the final maturation of follicles lHH transmitting a single dose in a dose 10 000 IU in 24 - 48 h after the last injection of follitropin alpha; to growth inhibition of endogenous LH levels and to control tonic LH levels frequently used agonist gonadotropin - releasing - hormone; common treatment scheme at This is the introduction of follitropin alfa injection from the beginning 2 weeks after the first morning agonist, and both drugs are used even to achieve adequate development of follicles. Dosing and Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of estradiol and ultrasound data) in order to stimulate growth of Biosphere dose Major Depressive Disorder (Clinical Depression) individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian treatment, usually starting with a dose of 75-150 IU / day in the absence of ovarian response dose gradually increasing to register increase in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid Air-Lift Bioreactor in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation morning in 1-2 days after the last injection administered once SFHE 5000 -10 000 IU lHH (in / m). Indications for use drugs: female infertility with hypo-or normohonadotropnoyu ovarian failure - follicular growth stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive technology (ART), fertilization in vitro, and intraplazmatychniy sperm injection. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for Mr injection of 75 IU, 150 IU in vial. Contraindications to morning use of drugs: hypersensitivity to morning drug, high levels of follicle stimulating hormone in primary ovarian failure, thyroid gland and adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), pregnancy, lactation. The main pharmaco-therapeutic action: stimulant ovulation. Side effects and complications in the use of drugs: nausea and vomiting, endocrine and gynecological status - ovarian hyperstimulation, which clinically appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead to the formation of large ovarian cysts, ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR and immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), the formation of a / t, which leads to inefficiency of therapy; locally - swelling, pain, itching in the place of others' injections. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU FSH and 75 IU LH vial., Lyophillisate for Mr injection of 150 IU in vial. Pharmacotherapeutic group: G03GA04 - gonadotropic hormones. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, flatulence, headache, moderate increase in ovarian formation of ovarian cysts, breast compression c-m ovarian hyperstimulation (lower abdomen pain, nausea, diarrhea, a slight increase in ovarian development of ovarian cysts of large cysts, ascites, hidrotoraksu, weight gain, increased risk of ectopic and multiple pregnancy), dry skin, hair loss, AR (fever, chills, here skin hyperemia) locally pain, swelling, rash, itching, irritation at the injection site preparation; thromboembolism, myalgia, arthralgia, weakness. Contraindications to the use of drugs: pregnancy and lactation, morning or increase the Extracorporeal Membrane Oxygenation of the ovaries is not associated with c-IOM polycystic ovarian metrorahiyi uncertain etiology, tumor of the uterus, ovaries or breasts. Contraindications to the use of drugs: pregnancy, increase or ovarian cysts not related to c-IOM polycystic ovarian gynecological bleeding of unknown origin, ovarian carcinoma, uterine or breast cancer, tumors of the hypothalamus or morning gland; hypersensitivity to the drug; cases of effective responses response to treatment can develop, for example through: the primary pathology of ovarian defects of genital organs incompatible with pregnancy; fibroyidni tumors of the uterus incompatible with pregnancy morning .